NCT06650540View on ClinicalTrials.gov

Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis

NANot yet recruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

October 22, 2025

Study Completion Date

December 30, 2026

Conditions
IVF
Interventions
DRUG

Levofloxacin Plus Metronidazole Suppositories

Administer a two-week course of Levofloxacin Plus Metronidazole Suppositories to patients diagnosed with chronic endometritis.

BIOLOGICAL

Levofloxacin co-administered with Metronidazole tablets

Administer a two-week course of Levofloxacin in combination with Metronidazole tablets to patients diagnosed with chronic endometritis.

Trial Locations (1)

100191

Peking university third hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT06650540 - Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis | Biotech Hunter | Biotech Hunter